Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature

Breast implant-associated (BIA) anaplastic large-cell lymphoma (ALCL) is a rare disease, comprising a small percentage of all non-Hodgkin lymphomas (NHLs), reportedly 2–3%. There is currently no established standard approach to the treatment of BIA ALCL. The first case on the development of ALCL in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: Richardson, Kristin, Alrifai, Taha, Grant-Szymanski, Kelly, Kouris, George J., Venugopal, Parameswaran, Mahon, Brett, Karmali, Reem
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5374895/
https://ncbi.nlm.nih.gov/pubmed/28413663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados